![](/images/graphics-bg.png)
Refractory Epistaxis due to Severe Factor V Deficiency with Inhibitor
Joint Authors
John, Elizabeth S.
Patel, Minesh D.
Hajdenberg, Julio
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-08-09
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Factor V deficiency secondary to inhibitors is extremely rare and can be caused by a wide collection of exposures such as bovine thrombin and beta lactamase antibiotics.
The management of factor V deficiency with inhibitor is a condition treated based on case reports due to the rarity of this condition.
We describe a complicated case of an elderly patient with severe factor V deficiency with high inhibitor titer refractory to FEIBA (anti-inhibitor coagulation complex) treated with NovoSeven concurrently with cyclosporine immunosuppression and Rituxan.
Given that there are no consensus guidelines on treatment, this case offers important insight into the therapeutic approaches that can be used to treat such patients.
American Psychological Association (APA)
John, Elizabeth S.& Patel, Minesh D.& Hajdenberg, Julio. 2015. Refractory Epistaxis due to Severe Factor V Deficiency with Inhibitor. Case Reports in Hematology،Vol. 2015, no. 2015, pp.1-3.
https://search.emarefa.net/detail/BIM-1058618
Modern Language Association (MLA)
John, Elizabeth S.…[et al.]. Refractory Epistaxis due to Severe Factor V Deficiency with Inhibitor. Case Reports in Hematology No. 2015 (2015), pp.1-3.
https://search.emarefa.net/detail/BIM-1058618
American Medical Association (AMA)
John, Elizabeth S.& Patel, Minesh D.& Hajdenberg, Julio. Refractory Epistaxis due to Severe Factor V Deficiency with Inhibitor. Case Reports in Hematology. 2015. Vol. 2015, no. 2015, pp.1-3.
https://search.emarefa.net/detail/BIM-1058618
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1058618